Please check your internet connection and try again.
# Clobazam (Oral Formulation)
## Overview
Clobazam is a benzodiazepine derivative with pharmacological properties that overlap with both benzodiazepines and barbiturates. It is primarily used as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome (LGS).
## Primary Indications
Adjunctive treatment of seizures in patients with Lennox-Gastaut syndrome (LGS).
## Adult Dosing
* **Initiation:** Start at 5 mg twice daily.
* **Titration:** Increase dose gradually based on clinical response and tolerability, with increases of 5-10 mg every week.
* **Maintenance:** Typical maintenance doses range from 10-20 mg twice daily.
* **Maximum:** Maximum recommended daily dose is 40 mg.
## Pediatric Dosing
Dosing is based on weight.
* **Initiation (2-10 years or <30 kg):** Start at 5 mg once daily.
* **Initiation (>10 years or ≥30 kg):** Start at 10 mg once daily.
* **Titration:** Increase dose gradually based on clinical response and tolerability.
* **Maintenance (2-10 years or <30 kg):** Typical maintenance doses range from 5-10 mg twice daily.
* **Maintenance (>10 years or ≥30 kg):** Typical maintenance doses range from 10-20 mg twice daily.
* **Maximum Pediatric Dose:** 20 mg daily for children weighing less than 30 kg, and 40 mg daily for children weighing 30 kg or more.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose reduction guidelines are established, but starting at the lower end of the dosing range and titrating slowly is recommended due to potential accumulation.
* **Renal Impairment:** Use with caution. No specific dose reduction guidelines are established.
## Contraindications
* Known hypersensitivity to clobazam or other benzodiazepines.
* Severe respiratory impairment.
* Severe hepatic impairment.
* Acute intoxication with alcohol, opioids, or other CNS depressants.
## Adverse Effects
Common adverse effects include somnolence, fatigue, drooling, constipation, decreased appetite, ataxia, and rash. Serious adverse effects may include severe skin reactions (e.g., Stevens-Johnson syndrome), suicidal behavior or ideation, respiratory depression, and withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, sedatives, other benzodiazepines):** Additive CNS depressant effects, potentially leading to profound sedation, respiratory depression, coma, and death. Use concurrently with extreme caution or avoid.
* **CYP3A4 Inhibitors/Inducers:** Clobazam is a substrate of CYP3A4. Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) may increase clobazam levels. Strong CYP3A4 inducers (e.g., rifampin, carbamazepine) may decrease clobazam levels.
* **Other Antiepileptic Drugs (AEDs):** Monitor for potential additive CNS depression and changes in AED efficacy.
## Monitoring
* Monitor for therapeutic effectiveness (reduction in seizure frequency).
* Monitor for adverse effects, especially somnolence, sedation, behavioral changes, and rash.
* Monitor for signs of withdrawal if discontinuation is planned; taper slowly.
* Monitor for signs of suicidal behavior or ideation.
## Clinical Pearls
* Clobazam is typically used as an adjunctive therapy for LGS and should not be used as monotherapy for seizure control.
* Given the risk of severe skin reactions, educate patients and caregivers to discontinue clobazam and seek immediate medical attention if a rash develops.
* Withdrawal symptoms can occur upon abrupt cessation, including rebound seizures. Tapering of the dose is recommended.
* Consider the risk of drug-induced liver injury and monitor liver function tests as clinically indicated.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Local protocols and patient-specific factors may necessitate adjustments to this general guidance.
